MoneyWorks4Me

Astrazeneca Pharma I - Quaterly Results

30 May 2025 Evaluate
The sales surged to Rs. 4804.80 millions, up 25.39% for the March 2025 quarter as against Rs. 3832.00 millions during the corresponding quarter previous year.The company has announced a 47.54% increase in its profits to Rs . 582.50  millions for the  quarter ended March 2025 compared to Rs. 394.80 millions in the corresponding quarter in the previous year.OP of the company witnessed a marginal growth to 1025.20 millions from 580.50 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 4804.80 3832.00 25.39 17162.90 12955.30 32.48 17162.90 12955.30 32.48
Other Income 161.50 86.60 86.49 406.30 348.00 16.75 406.30 348.00 16.75
PBIDT 1025.20 580.50 76.61 2946.00 2192.50 34.37 2946.00 2192.50 34.37
Interest 6.80 -0.70 -1071.43 14.60 12.00 21.67 14.60 12.00 21.67
PBDT 961.60 581.20 65.45 1963.50 2344.80 -16.26 1963.50 2344.80 -16.26
Depreciation 176.90 37.60 370.48 399.90 149.40 167.67 399.90 149.40 167.67
PBT 784.70 543.60 44.35 1563.60 2195.40 -28.78 1563.60 2195.40 -28.78
TAX 202.20 148.80 35.89 406.20 580.30 -30.00 406.20 580.30 -30.00
Deferred Tax -27.00 -6.40 321.88 -199.20 -9.00 2113.33 -199.20 -9.00 2113.33
PAT 582.50 394.80 47.54 1157.40 1615.10 -28.34 1157.40 1615.10 -28.34
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 21.34 15.15 40.85 17.16 16.92 1.43 17.16 16.92 1.43
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..